欧林生物：发行境外上市股份备案申请材料获证监会接收

Core Viewpoint - The company has submitted an application for overseas public offering and listing to the Hong Kong Stock Exchange on November 25, 2025, and has published the application materials on the same day [1] Group 1 - The application materials for the public offering have been accepted by the China Securities Regulatory Commission [1] - The issuance and listing are subject to approval, authorization, or filing by relevant regulatory agencies and stock exchanges, indicating uncertainty in the process [1] - The company will disclose updates on the progress of the application in a timely manner [1]